Terapia Genica e Cellulare

Laboratori 2020/2021 - Terapia Genica e Cellulare

Ciascun candidato, al momento della sottomissione della domanda di ammissione, deve selezionare da 3 a 5 progetti, non necessariamente afferenti ad uno stesso curriculum, tra tutti quelli elencati nelle pagine dei curricula stessi.

3 BORSE A PROGETTO:

Borsa a progetto GCT1 

BERNARDO MARIA ESTER 

Unit: Pathogenesis and Therapy of Primary Immunodeficiencies

Genetic reprogramming of MSCs to improve the efficacy of HSC transplantation

Borsa a progetto GCT2 

GENTNER BERNHARD

Unit: Translational Stem Cell & Leukemia Research

New gene therapy approaches for malignant diseases

Borsa a progetto GCT3 

NALDINI LUIGI

Unit: Gene transfer technologies and new gene therapy strategies

Uncovering cellular responses and optimizing strategies for cutting-edge gene editing strategies in human hematopoietic cells

GREGORI SILVIAFCSR Fronzaroli

Unit: Mechanisms of Peripheral Tolerance

Personalized antigen-specific immunotherapy to halt autoimmunity in Type 1 Diabetic

MENEGHINI VASCO - FCSR Fronzaroli

Unit: Gene/Neural Stem Cell Therapy for Lysosomal Storage Diseases

Development of gene editing strategies targeting glial cells for the treatment of rare neurodegenerative disorders

MONTINI EUGENIO 

Unit: Safety of gene therapy and insertional mutagenesis

Understanding the role of insertional mutagenesis in oncogene induced senescence

NALDINI LUIGI FCSR Fronzaroli

Unit: Gene transfer technologies and new gene therapy strategies 

Generation of hyperfunctional targets for HSC homing and retention, using a directed-evolution platform

OSTUNI RENATO - FCSR Fronzaroli

Unit: Genomics of the innate immune system

Identification and targeting of suppressors of inflammatory gene expression in macrophages

PIEMONTI LORENZO - FCSR Fronzaroli

Unit: DIABETES RESEARCH INSTITUTE – BETA CELL BIOLOGY UNIT

Identification of β cell differentiation-prone iPSC for personalized cell therapy in diabetes